Roger R Reddel Selected Research

Roger R Reddel Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 01/2002
9	Carcinogenesis 01/2017 - 06/2006
7	Breast Neoplasms (Breast Cancer) 06/2018 - 03/2002
5	Leukemia 07/2010 - 04/2005
4	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 04/2005
2	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2012
2	Neuroblastoma 10/2021 - 01/2021
1	Hypoxia (Hypoxemia) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 10/2021
1	Adenocarcinoma of Lung 10/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Fanconi Anemia (Fanconi's Anemia) 01/2019
1	Infections 01/2019
1	Carcinoma (Carcinomatosis) 06/2015
1	Inflammation (Inflammations) 01/2015
1	Brain Ischemia (Cerebral Ischemia) 01/2015
1	Retinal Degeneration 01/2015
1	Bone Marrow Failure Disorders 10/2014
1	Neoplasm Metastasis (Metastasis) 02/2013
1	Colorectal Neoplasms (Colorectal Cancer) 02/2013
1	Brain Neoplasms (Brain Tumor) 01/2012
1	Malignant Mesothelioma 09/2011
1	Glioma (Gliomas) 07/2008
1	Mesothelioma 07/2008
1	Astrocytoma (Pilocytic Astrocytoma) 04/2005

Drug/Important Bio-Agent (IBA)

40	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2021 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 03/2002
5	EnzymesIBA 01/2018 - 03/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 02/2013
3	telomerase RNA (bTR)IBA 01/2019 - 06/2008
3	Histones (Histone)IBA 01/2012 - 12/2007
3	Messenger RNA (mRNA)IBA 10/2011 - 03/2002
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
2	ProteomeIBA 01/2022 - 11/2019
2	Procainamide (Procan)FDA LinkGeneric 01/2022 - 11/2019
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2011
2	A-Form DNA (A-DNA)IBA 01/2019 - 01/2013
2	Estrogens (Estrogen)FDA Link 09/2017 - 03/2002
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2015 - 04/2008
2	Small Interfering RNA (siRNA)IBA 01/2015 - 04/2014
2	Estrogen ReceptorsIBA 04/2013 - 03/2002
2	ParaffinIBA 07/2010 - 01/2005
2	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2009 - 09/2002
2	RibonucleoproteinsIBA 04/2009 - 03/2007
2	Telomere-Binding ProteinsIBA 08/2007 - 04/2005
1	Retinaldehyde (Retinal)IBA 01/2022
1	OTX015IBA 01/2021
1	tetraethylpyrazine (TEP)IBA 01/2021
1	carfilzomibIBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	Biological ProductsIBA 09/2020
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 06/2018
1	Interferon-gamma (Interferon, gamma)IBA 06/2018
1	LuciferasesIBA 09/2017
1	withaferin AIBA 01/2017
1	RNA Splice SitesIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Tripeptidyl-Peptidase 1IBA 10/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2013
1	7- O- (2,6- dideoxy- 2- fluorotalopyranosyl)daunomycinoneIBA 01/2012
1	3' Untranslated Regions (3' UTR)IBA 10/2011
1	AntigensIBA 10/2011
1	1-methyl-1-piperidinomethane sulfonateIBA 09/2011
1	Antiviral Agents (Antivirals)IBA 01/2010
1	Progesterone FDA LinkGeneric 07/2009
1	ChromatinIBA 06/2009
1	Decitabine FDA Link 12/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2007
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 12/2007
1	Transforming Growth Factor beta2IBA 12/2007
1	glucose-regulated proteinsIBA 06/2006
1	mortalinIBA 06/2006
1	mirfentanilIBA 07/2005
1	Promyelocytic Leukemia ProteinIBA 04/2005
1	Coloring Agents (Dyes)IBA 08/2002
1	MKT 077IBA 08/2002
1	rhodacyanineIBA 08/2002
1	teleocalcinIBA 03/2002
1	Estrogen Receptor Modulators (Antiestrogen)IBA 03/2002
1	Hormones (Hormone)IBA 03/2002

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2002
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2009
1	Aftercare (After-Treatment) 12/2007
1	Drug Therapy (Chemotherapy) 03/2002